参考文献/References:
[1] CHIANG J Y L,FERRELL J M.Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy[J].Am J Physiol Gastrointest Liver Physiol,2020,318(3):g554-g573.
[2] KATSUMA S,HIRASAWA A,TSUJIMOTO G.Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1[J].Biochem Biophys Res Commun,2005,329(1):386-390.
[3] SHI Y,SU W,ZHANG L,et al.TGR5 regulates macrophage inflammation in nonalcoholic steatohepatitis by modulating NLRP3 inflammasome activation[J].Front Immunol,2020,11:609060.
[4] DING L,YANG Q,ZHANG E,et al.Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice[J].Acta Pharm Sin B,2021,11(6):1541-1554.
[5] HUANG S,MA S,NING M,et al.TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice[J].Metabolism,2019,99:45-56.
[6] LI W,ZHUANG T,WANG Z,et al.Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway[J].Phytomedicine,2023,119:154982.
[7] JIN G,YAO X,LIU D,et al.Inducible nitric oxide synthase accelerates nonalcoholic fatty liver disease progression by regulating macrophage autophagy[J].Immun Inflamm Dis,2023,11(12):e1114.
[8] VAN NIEROP F S,SCHELTEMA M J,EGGINK H M,et al.Clinical relevance of the bile acid receptor TGR5 in metabolism[J].Lancet Diabetes Endocrinol,2017,5(3):224-233.
[9] SINHA S R,HAILESELASSIE Y,NGUYEN L P,et al.Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation[J].Cell Host Microbe,2020,27(4):659-670.e5.
[10] KAWAMATA Y,FUJII R,HOSOYA M,et al.A G protein-coupled receptor responsive to bile acids[J].J Biol Chem,2003,278(11):9435-9440.
[11] MARUYAMA T,MIYAMOTO Y,NAKAMURA T,et al.Identification of membrane-type receptor for bile acids(M-BAR)[J].Biochem Biophys Res Commun,2002,298(5):714-719.
[12] YANG F,MAO C,GUO L,et al.Structural basis of GPBAR activation and bile acid recognition[J].Nature,2020,587(7834):499-504.
[13] MA K,TANG D,YU C,et al.Progress in research on the roles of TGR5 receptor in liver diseases[J].Scand J Gastroenterol,2021,56(6):717-726.
[14] SORRENTINO G,PERINO A,YILDIZ E,et al.Bile acids signal via TGR5 to activate intestinal stem cells and epithelial regeneration[J].Gastroenterology,2020,159(3):956-968.e8.
[15] WATANABE M,HOUTEN S M,MATAKI C,et al.Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation[J].Nature,2006,439(7075):484-489.
[16] SASAKI T,WATANABE Y,KUBOYAMA A,et al.Muscle-specific TGR5 overexpression improves glucose clearance in glucose-intolerant mice[J].J Biol Chem,2021,296:100131.
[17] KEITEL V,HÄUSSINGER D.TGR5 in cholangiocytes[J].Curr Opin Gastroenterol,2013,29(3):299-304.
[18] CAO H,CHEN Z X,WANG K,et al.Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect[J].Sci Rep,2016,6:28676.
[19] LI T,CHIANG J Y.Bile acid signaling in metabolic disease and drug therapy[J].Pharmacol Rev,2014,66(4):948-983.
[20] FUNABASHI M,GROVE T L,WANG M,et al.A metabolic pathway for bile acid dehydroxylation by the gut microbiome[J].Nature,2020,582(7813):566-570.
[21] LIEU T,JAYAWEERA G,BUNNETT N W.GPBA:A GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation[J].Br J Pharmacol,2014,171(5):1156-1166.
[22] YU D D,SOUSA K M,MATTERN D L,et al.Stereoselective synthesis,biological evaluation,and modeling of novel bile acid-derived G-protein coupled bile acid receptor 1(GP-BAR1,TGR5)agonists[J].Bioorg Med Chem,2015,23(7):1613-1628.
[23] KUMAR D P,ASGHARPOUR A,MIRSHAHI F,et al.Activation of transmembrane bile acid receptor TGR5 modulates pancreatic islet α cells to promote glucose homeostasis[J].J Biol Chem,2016,291(13):6626-6640.
[24] PELLICCIARI R,FIORUCCI S,CAMAIONI E,et al.6alpha-ethyl-chenodeoxycholic acid(6-ECDCA),a potent and selective FXR agonist endowed with anticholestatic activity[J].J Med Chem,2002,45(17):3569-3572.
[25] FIORUCCI S,DI GIORGIO C,DISTRUTTI E.Obeticholic acid:An update of its pharmacological activities in liver disorders[J].Handb Exp Pharmacol,2019,256:283-295.
[26] PELLICCIARI R,GIOIELLO A,MACCHIARULO A,et al.Discovery of 6alpha-ethyl-23(S)-methylcholic acid(S-EMCA,INT-777)as a potent and selective agonist for the TGR5 receptor,a novel target for diabesity[J].J Med Chem,2009,52(24):7958-7961.
[27] NAKHI A,MCDERMOTT C M,STOLTZ K L,et al.7-methylation of chenodeoxycholic acid derivatives yields a substantial increase in TGR5 receptor potency[J].J Med Chem,2019,62(14):6824-6830.
[28] 陈卫东,赵世振,王艳东,等 苯乙基咪唑类衍生物及其用途:CN111763173A[P/OL].2022-11-01[2024-11-08].https://www.cqvip.com/doc/patent/3238265114.
[29] DEHMLOW H,ERICKSON S D,MATTEI P,et al.1,2-pyridazine,1,6-pyridazine or pyrimidine-benzamide derivatives as GPBAR1 modulators:WO2013149977[P/OL].2013-10-10[2024-11-08].https://pubchem.ncbi.nlm.nih.gov/patent/WO2013149977-A1.
[30] LEWIS J G,LEADBETTER M R,CALDWELL J,et al.Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists:US2017174718[P/OL].2017-06-22[2024-11-08].https://pubchem.ncbi.nlm.nih.gov/patent/US-2017174718-A1.
[31] 邱曲真.5,5-二甲基环己-1-烯类衍生物及其在代谢性疾病中的应用:CN111303067A[P/OL].2020-06-19[2024-11-08].https://www.cqvip.com/doc/patent/1995350933.
[32] PRATT B,WANG T L,MARTIN R,et al.Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity:WO2010093845 [P/OL].2010-08-19[2024-11-08].https://pubchem.ncbi.nlm.nih.gov/patent/WO-2010093845-A1.
[33] CHARTON J,DEPREZ B,LEROUX F,et al.Imidazol-or 1,2,4-triazol-derivatives and their use:WO2015189330[P/OL].2015-12-17[2024-11-08].https://pubchem.ncbi.nlm.nih.gov/patent/WO-2015189330-A1.
[34] MARTIN R E,BISSANTZ C,GAVELLE O,et al.2-phenoxy-nicotinamides are potent agonists at the bile acid receptor GPBAR1(TGR5)[J].ChemMedChem,2013,8(4):569-576.
[35] MIYATA S,KAWASHIMA Y,SAKAI M,et al.Discovery,optimization,and evaluation of non-bile acid FXR/TGR5 dual agonists[J].Sci Rep,2021,11(1):9196.
[36] PHILLIPS D P,GAO W,YANG Y,et al.Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent,orally bioavailable TGR5(GPBAR1)agonists:Structure-activity relationships,lead optimization,and chronic in vivo efficacy[J].J Med Chem,2014,57(8):3263-3282.
[37] CHOBANIAN H,DEMONG D,GUO Y,et al.Antidiabetic bicyclic compounds:US10662171[P/OL].2020-05-26[2024-11-08].https://pubchem.ncbi.nlm.nih.gov/patent/US-10662171-B2.
[38] PARK E J,CHOI J,LEE K C,et al.Emerging PEGylated non-biologic drugs[J].Expert Opin Emerg Drugs,2019,24(2):107-119.
[39] HOGUET V,LASALLE M,MAINGOT M,et al.Beyond the rule of 5:Impact of PEGylation with various polymer sizes on pharmacokinetic properties,structure-properties relationships of mPEGylated small agonists of TGR5 receptor[J].J Med Chem,2021,64(3):1593-1610.
[40] DUAN H,NING M,ZOU Q,et al.Discovery of intestinal targeted TGR5 agonists for the treatment of type 2 diabetes[J].J Med Chem,2015,58(8):3315-3328.
[41] CHEN T,REICH N W,BELL N,et al.Design of gut-restricted thiazolidine agonists of G protein-coupled bile acid receptor 1(GPBAR1,TGR5)[J].J Med Chem,2018,61(17):7589-7613.
[42] GENET C,SCHMIDT C,STREHLE A,et al.Redefining the TGR5 triterpenoid binding pocket at the C-3 position[J].ChemMedChem,2010,5(12):1983-1988.
[43] SATO H,GENET C,STREHLE A,et al.Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea[J].Biochem Biophys Res Commun,2007,362(4):793-798.
[44] LO S H,LI Y,CHENG K C,et al.Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats[J].Naunyn Schmiedebergs Arch Pharmacol,2017,390(11):1097-1104.
[45] HORIBA T,KATSUKAWA M,MITA M,et al.Dietary obacunone supplementation stimulates muscle hypertrophy,and suppresses hyperglycemia and obesity through the TGR5 and PPARγ pathway[J].Biochem Biophys Res Commun,2015,463(4):846-852.
[46] ONO E,INOUE J,HASHIDUME T,et al.Anti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat diet[J].Biochem Biophys Res Commun,2011,410(3):677-681.
[47] YANG Z,LI J,XIONG F,et al.Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells[J].Exp Cell Res,2016,346(2):241-247.
[48] GENET C,STREHLE A,SCHMIDT C,et al.Structure-activity relationship study of betulinic acid,a novel and selective TGR5 agonist,and its synthetic derivatives:potential impact in diabetes[J].J Med Chem,2010,53(1):178-190.
[49] LO S H,CHENG K C,LI Y X,et al.Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay[J].Drug Des Devel Ther,2016,10:2669-2676.
[50] WANG X Y,ZHANG S Y,LI J,et al.Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy[J].Acta Pharmacol Sin,2014,35(11):1463-1472.[51] YUN Y,ZHANG C,GUO S,et al.Identification of betulinic acid derivatives as potent TGR5 agonists with antidiabetic effects via humanized TGR5(H88Y)mutant mice[J].J Med Chem,2021,64(16):12181-12199.[52] ZHUO N,YUN Y,ZHANG C,et al.Discovery of betulinic acid derivatives as gut-restricted TGR5 agonists:Balancing the potency and physicochemical properties[J].Bioorg Chem,2024,144:107132.[53] WANG L Y,CHENG K C,LI Y,et al.Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats[J].Biomed Pharmacother,2017,95:599-604.[54] JIANG L S,LI W,ZHUANG T X,et al.Ginsenoside Ro ameliorates high-fat diet-induced obesity and insulin resistance in mice via activation of the G protein-coupled bile acid receptor 5 pathway[J].J Pharmacol Exp Ther,2021,377(3):441-451.[55] GUO N,TONG T,REN N,et al.Saponins from seeds of Genus Camellia:Phytochemistry and bioactivity[J].Phytochemistry,2018,149:42-55.[56] ZHU H,WANG K,CHEN S,et al.Saponins from Camellia sinensis seeds stimulate GIP secretion in mice and STC-1 Cells via SGLT1 and TGR5[J].Nutrients,2022,14(16):3413.[57] JÄGER S,TROJAN H,KOPP T,et al.Pentacyclic triterpene distribution in various plants-rich sources for a new group of multi-potent plant extracts[J].Molecules,2009,14(6):2016-2031.[58] CHIANESE G,GOLIN-PACHECO S D,TAGLIALATELA-SCAFATI O,et al.Bioactive triterpenoids from the caffeine-rich plants guayusa and maté[J].Food Res Int,2019,115:504-510.[59] JAFRI L,SALEEM S,CALDERWOOD D,et al.Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion[J].Peptides,2016,78:51-58.[60] POLS T W,AUWERX J,SCHOONJANS K.Targeting the TGR5-GLP-1 pathway to combat type 2 diabetes and non-alcoholic fatty liver disease[J].Gastroenterol Clin Biol,2010,34(4-5):270-273.[61] WANG L Y,CHENG K C,LI Y,et al.The Dietary furocoumarin imperatorin increases plasma GLP-1 levels in type 1-like diabetic rats[J].Nutrients,2017,9(11):1192.[62] KIRCHWEGER B,KRATZ J M,LADURNER A,et al.In silico workflow for the discovery of natural products activating the G protein-coupled bile acid receptor 1[J].Front Chem,2018,6:242.[63] GU M,FENG Y,CHEN Y,et al.Deoxyschizandrin ameliorates obesity and non-alcoholic fatty liver disease:Involvement of dual farnesyl X receptor/G protein-coupled bile acid receptor 1 activation and leptin sensitization[J].Phytother Res,2023,37(7):2771-2786.[64] CHI B,ZHANG M,SUN L,et al.Study on the hypotensive effect and mechanism of hawthorn(Crataegus pinnatifida)fruits and hyperoside in spontaneously hypertensive rats[J].Food Funct,2024,15(10):5627-5640.[65] ZHU H,WANG G,BAI Y,et al.Natural bear bile powder suppresses neuroinflammation in lipopolysaccharide-treated mice via regulating TGR5/AKT/NF-κB signaling pathway[J].J Ethnopharmacol,2022,289:115063.[66] HALKIAS C,DARBY W G,FELTIS B N,et al.Marine bile natural products as agonists of the TGR5 receptor[J].J Nat Prod,2021,84(5):1507-1514.